Patients newly diagnosed with breast cancer face a series of complex decisions regarding locoreginal and systemic treatment. Currently many of these decisions do not meet the definition of a high quality decision, defined as one that is both informed (based on an accurate understanding of the treatment risks and benefits) and preference-concordant (consistent with the patient's underlying preferences). I Can Decide evaluates the impact of an innovative decision tool on locoregional and systemic therapy decision making for newly diagnosed breast cancer patients.
The I Can Decide Dashboard links the I Can Decide patient website to a clinic dashboard. Some of the information patients enter on the website will be shared with the clinic. The goal is to improve communication and help patients make informed treatment decisions.
Evaluate the impact of the clinic dashboard on the quality of treatment decision-making among newly diagnosed patients with early stage invasive breast cancer.
Participants are newly diagnosed patients with invasive early stage breast cancer.